Cadence Capital Management’s iRadimed IRMD Stock Holding History

Cadence Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$340K	Sell	15,922 -53,155	-77%	-$1.19M	0.08%	220
2020 Q2	$1.6M	Sell	69,077 -32,643	-32%	-$701K	0.23%	123
2020 Q1	$2.17M	Sell	101,720 -5,323	-5%	-$127K	0.37%	67
2019 Q4	$2.5M	Sell	107,043 -10,913	-9%	-$255K	0.27%	82
2019 Q3	$2.48M	Sell	117,956 -7,795	-6%	-$159K	0.35%	89
2019 Q2	$2.57M	Sell	125,751 -4,204	-3%	-$99K	0.26%	111
2019 Q1	$3.65M	Buy	129,955 +51,050	+65%	+$1.34M	0.33%	71
2018 Q4	$1.93M	Buy	78,905 +6,113	+8%	+$164K	0.19%	164
2018 Q3	$2.7M	Sell	72,792 -71,174	-49%	-$1.92M	0.15%	183
2018 Q2	$2.99M	Buy	143,966 +31,437	+28%	+$556K	0.18%	132
2018 Q1	$1.59M	Buy	112,529 +91,431	+433%	+$1.3M	0.1%	280
2017 Q4	$320K	Buy	+21,098	New	+$268K	0.02%	566

Other funds holding IRMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Cadence Capital Management's IRMD Position: Q3 2020 in Review

Cadence Capital Management reduced its iRadimed (IRMD) stake by 77% in Q3 2020, selling an estimated $1.19M and leaving 15,922 shares worth $340K. The position accounts for 0.08% of the portfolio, ranked #220.

Cadence Capital Management first reported a position in IRMD in Q4 2017 and has held it in 12 quarters since. The position peaked at $3.65M in Q1 2019. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2020.

Cadence Capital Management held 15,922 shares of iRadimed worth $340K as of Q3 2020.
Cadence Capital Management sold 53,155 iRadimed shares in Q3 2020, an estimated $1.19M.
iRadimed made up 0.08% of Cadence Capital Management's portfolio in Q3 2020, its #220 holding.
Cadence Capital Management first reported a position in iRadimed in Q4 2017 and has held it in 12 quarters since.
Cadence Capital Management's iRadimed position peaked at $3.65M in Q1 2019.
62 funds tracked by Wall St. Rank held iRadimed as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.